Pathways Linking Late-Life Depression to MCI & Dementia
Pathways Linking Late-Life Depression to MCI & Dementia
批准号:
7485702
负责人:
MERYL A BUTTERS
金额:
$32.29万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-08-08 至 2010-07-31
关键词:
AddressAgeAgreementAlzheimer&aposs DiseaseAlzheimer&aposs disease riskAtrophicAutopsyAwardBehavior DisordersBiological MarkersBrainBrain regionButterCerebrovascular CirculationCerebrovascular DisordersClinicClinicalCognition DisordersCognitiveCognitive deficitsDataDementiaDepressed moodDepthDevelopmentDiagnosisDiagnosticEducationElderlyEnrollmentEtiologyEvaluationExhibitsFrequenciesFunctional Magnetic Resonance ImagingFutureGoalsImpaired cognitionIndividualInjuryIntervention StudiesJointsLeadLinkMeasuresMemoryMemory impairmentMental DepressionMentored Research Scientist Development AwardMethodsModelingMood DisordersNatural HistoryNerve DegenerationOutcomePathway interactionsPatientsPhenotypePopulationPreventiveProcessPublic HealthPublishingPurposeRateRecording of previous eventsReportingResearchResearch InfrastructureResearch PersonnelRiskRisk FactorsSeriesStructureSubgroupTestingTimeUniversitiesVascular DementiaVisuospatialWorkagedcaudate nucleuscerebrovascularcognitive changecognitive functioncohortconceptdepressive symptomsexecutive functionfollow-upfrontal lobegeriatric depressionindexinginjuredmild neurocognitive impairmentmood regulationneurobehavioral disorderneuroimagingneuropathologyneuropsychologicalnovelprocessing speedprogressive neurodegenerationputamenwhite matter
中文摘要
描述(由研究者提供):本R01修订申请的目的是探讨晚年抑郁(LLD)、认知功能障碍和进行性神经变性之间的关系。指导假设是LLD患者由于不同的潜在神经病理改变而发生认知障碍,这种改变通常表现为轻度认知障碍(MCI)。这些神经病理和认知变化是风险调节剂,降低大脑储备能力,进而增加患阿尔茨海默病(AD)的风险。为了实现这一目标,我们将招募LLD、MCI和正常对照受试者,以丰富我们现有的队列(通过Butters博士现有的K01奖(MH01684)“晚年抑郁症的认知功能过程”收集),共包括150名老年人、非痴呆、非抑郁受试者、60名非抑郁MCI受试者和270名LLD受试者。利用匹兹堡大学晚年情绪障碍干预研究中心(MH52247)和阿尔茨海默病研究中心(AG05133)的联合基础设施,我们将完成详细的神经行为研究!评估,包括临床,神经心理学,神经影像学和生物学标记,使用这些数据来评估与轻度认知障碍或痴呆发展相关的因素。研究对象将在至少三年的时间里每年进行一次研究,这使我们能够利用纵向数据来评估一系列相互关联的假设,这些假设假设了老年抑郁症患者产生认知障碍的途径,并可能导致一些人患上痴呆症。
英文摘要
DESCRIPTION (provided by investigator): The goal of this revised R01 application is to investigate the relationships among late-life depression (LLD), cognitive impairment and progressive neurodegeneration. The guiding hypothesis is that LLD patients have evolving cognitive impairments as a consequence of distinct underlying neuropathological changes, which frequently are expressed as Mild Cognitive Impairment (MCI). These neuropathological and cognitive changes are risk modifiers, lowering brain reserve capacity, and in turn, increasing risk of developing Alzheimer's Disease (AD). In order to pursue this goal we will enroll LLD, MCI, and normal control subjects to enrich our existing cohort (gathered through Dr. Butters' existing K01 Award (MH01684), "The Course of Cognitive Functioning in Late-Life depression" to include a total of 150 elderly, non-demented, non-depressed subjects, 60 nondepressed MCI subjects and 270 LLD subjects. Using the joint infrastructure of the University of Pittsburgh's Intervention Research Center for Late-Life Mood Disorders (MH52247) and the Alzheimer's Disease Research Center (AG05133) we will complete a detailed neurobehaviora! evaluation, including clinical, neuropsychological, neuroimaging and biological markers, using these data to evaluate the factors associated with the development of MCI or dementia. Subjects will be studied annually for at least three years, allowing us to use longitudinal data to evaluate a series of linked hypotheses that postulate the pathways by which elderly, depressed patients develop cognitive impairment, and which may lead some to develop dementia.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Major Depression and Molecular Senescence: The Role of Sleep
-
批准号:10493092
-
项目类别:
-
资助金额:$10.98万
-
财政年份:2021
-
负责人:MERYL A BUTTERS
-
依托单位:
3/5 Neurocognitive and neuroimaging biomarkers: predicting progression towards dementia in patients with treatment resistant late-life depression
-
批准号:9755505
-
项目类别:
-
资助金额:$49.83万
-
财政年份:2017
-
负责人:MERYL A BUTTERS
-
依托单位:
3/5 Neurocognitive and neuroimaging biomarkers: predicting progression towards dementia in patients with treatment resistant late-life depression
-
批准号:9420061
-
项目类别:
-
资助金额:$45.24万
-
财政年份:2017
-
负责人:MERYL A BUTTERS
-
依托单位:
3/5 Neurocognitive and neuroimaging biomarkers: predicting progression towards dementia in patients with treatment resistant late-life depression
-
批准号:9981019
-
项目类别:
-
资助金额:$43.18万
-
财政年份:2017
-
负责人:MERYL A BUTTERS
-
依托单位:
3/5 Neurocognitive and neuroimaging biomarkers: predicting progression towards dementia in patients with treatment resistant late-life depression
-
批准号:10223153
-
项目类别:
-
资助金额:$40.59万
-
财政年份:2017
-
负责人:MERYL A BUTTERS
-
依托单位:
Amyloid, white matter hyperintensities & outcomes of late-life depression
-
批准号:8235036
-
项目类别:
-
资助金额:$49.59万
-
财政年份:2009
-
负责人:MERYL A BUTTERS
-
依托单位:
Amyloid, white matter hyperintensities & outcomes of late-life depression
-
批准号:8488366
-
项目类别:
-
资助金额:$17.05万
-
财政年份:2009
-
负责人:MERYL A BUTTERS
-
依托单位:
Amyloid, white matter hyperintensities & outcomes of late-life depression
-
批准号:7649755
-
项目类别:
-
资助金额:$46.14万
-
财政年份:2009
-
负责人:MERYL A BUTTERS
-
依托单位:
Amyloid, White Matter Hyperintensities & Outcomes of Late-Life Depression
-
批准号:8882920
-
项目类别:
-
资助金额:$6.53万
-
财政年份:2009
-
负责人:MERYL A BUTTERS
-
依托单位:
Pathways Linking Late-Life Depression to MCI & Dementia
-
批准号:7896344
-
项目类别:
-
资助金额:$33.18万
-
财政年份:2009
-
负责人:MERYL A BUTTERS
-
依托单位:
Amyloid, white matter hyperintensities & outcomes of late-life depression
-
批准号:8049633
-
项目类别:
-
资助金额:$49.75万
-
财政年份:2009
-
负责人:MERYL A BUTTERS
-
依托单位:
Amyloid, white matter hyperintensities & outcomes of late-life depression
-
批准号:8417720
-
项目类别:
-
资助金额:$35.77万
-
财政年份:2009
-
负责人:MERYL A BUTTERS
-
依托单位:
Amyloid, white matter hyperintensities & outcomes of late-life depression
-
批准号:7804613
-
项目类别:
-
资助金额:$50.77万
-
财政年份:2009
-
负责人:MERYL A BUTTERS
-
依托单位:
Pathways Linking Late-Life Depression to MCI & Dementia
-
批准号:7107880
-
项目类别:
-
资助金额:$35.12万
-
财政年份:2005
-
负责人:MERYL A BUTTERS
-
依托单位:
Pathways Linking Late-Life Depression to MCI & Dementia
-
批准号:7261397
-
项目类别:
-
资助金额:$32.61万
-
财政年份:2005
-
负责人:MERYL A BUTTERS
-
依托单位:
Pathways Linking Late-Life Depression to MCI & Dementia
-
批准号:6979922
-
项目类别:
-
资助金额:$35.56万
-
财政年份:2005
-
负责人:MERYL A BUTTERS
-
依托单位:
Pathways Linking Late-Life Depression to MCI & Dementia
-
批准号:7668406
-
项目类别:
-
资助金额:$33.44万
-
财政年份:2005
-
负责人:MERYL A BUTTERS
-
依托单位:
Pharmacotherapy of Latelife Generalized Anxiety Disorder
-
批准号:7343166
-
项目类别:
-
资助金额:$16.05万
-
财政年份:2005
-
负责人:MERYL A BUTTERS
-
依托单位:
Pharmacotherapy of Latelife Generalized Anxiety Disorder
-
批准号:7161371
-
项目类别:
-
资助金额:$25.98万
-
财政年份:2005
-
负责人:MERYL A BUTTERS
-
依托单位:
COURSE OF COGNITIVE FUNCTIONING IN LATE LIFE DEPRESSION
-
批准号:6736336
-
项目类别:
-
资助金额:$11.65万
-
财政年份:2000
-
负责人:MERYL A BUTTERS
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
-
批准号:82505677
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:吕雨霏
-
依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
-
批准号:82574874
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2025
-
负责人:刘天华
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位: